Ceftriaxone (Page 7 of 8)
REFERENCES
-
Barnett ED, Teele DW, Klein JO, et al. Comparison of Ceftriaxone and Trimethoprim-Sulfamethoxazole for Acute Otitis Media. Pediatrics. Vol. 99, No. 1, January 1997.
Manufactured by:
HIKMA FARMACÊUTICA (PORTUGAL), S.A.
Estrada do Rio da Mó, nº 8, 8A e 8B – Fervença — 2705 – 906 Terrugem SNT, PORTUGAL
Distributed by:
WEST-WARD PHARMACEUTICALS
Eatontown, NJ 07724 USA
Revised: August 2020
PIN149-WES/9
PRINCIPAL DISPLAY PANEL
NDC 0143-9859-01
Rx only
CEFTRIAXONE
FOR INJECTION, USP
250 mg/Vial
EQUIVALENT TO 250 MG CEFTRIAXONE
FOR IV OR IM USE
Single Dose Vial
PROTECT FROM LIGHT
A 350 mg/mL concentration is not recom-
mended for the 250 mg vial since it may
not be possible to withdraw the entire
contents.
For IV or IM administration and USUAL
DOSAGE: See package insert.
Storage Prior to Reconstitution: Store
powder at 20º to 25ºC (68º to 77ºF) [See
USP Controlled Room Temperature].
Storage After Reconstitution: See packageinsert.
NDC 0143-9859-25
Rx only
CEFTRIAXONE
FOR INJECTION, USP
250 mg/Vial
EQUIVALENT TO 250 MG CEFTRIAXONE
FOR IV OR IM USESingle Dose Vial
PRINCIPAL DISPLAY PANEL
NDC 0143-9858-01
Rx only
CEFTRIAXONE
FOR INJECTION, USP
500 mg/Vial
EQUIVALENT TO 500 MG CEFTRIAXONE
FOR IV OR IM USE
Single Dose Vial
PROTECT FROM LIGHT
For IM administration: Reconstitute with 1 mL 1%
Lidocaine Hydrochloride Injection, USP or Sterile
Water for Injection, USP. Each 1 mL of solution con-
tains approximately 350 mg equivalent of ceftriaxone.
For IV administration: Reconstitute with 4.8 mL of an
IV diluent specified in the accompanying package
insert. Each 1 mL of solution contains approximately
100 mg equivalent of ceftriaxone. Withdraw entire
contents and dilute to the desired concentration with
the appropriate IV diluent.
USUAL DOSAGE and Storage After Reconstitution:
See package insert. Storage Prior to Reconstitution:
Store powder at 20º to 25ºC (68º to 77ºF) [See USPControlled Room Temperature].
NDC 0143-9858-25
Rx only
CEFTRIAXONE
FOR INJECTION, USP
500 mg/Vial
EQUIVALENT TO 500 MG CEFTRIAXONE
FOR IV OR IM USESingle Dose Vial
PRINCIPAL DISPLAY PANEL
NDC 0143-9857-01
Rx only
CEFTRIAXONE
FOR INJECTION, USP
1 gram/V ial
EQUIVALENT TO 1 GRAM CEFTRIAXONE
FOR IV OR IM USE
Single Dose Vial
PROTECT FROM LIGHT
For IM administration: Reconstitute with 2.1 mL 1%
Lidocaine Hydrochloride Injection, USP or Sterile
Water for Injection, USP. Each 1 mL of solution con-
tains approximately 350 mg equivalent of ceftriaxone.
For IV administration: Reconstitute with 9.6 mL of an
IV diluent specified in the accompanying package
insert. Each 1 mL of solution contains approximately
100 mg equivalent of ceftriaxone. Withdraw entire
contents and dilute to the desired concentration with
the appropriate IV diluent.
USUAL DOSAGE and Storage After Reconstitution:
See package insert. Storage Prior to Reconstitution:
Store powder at 20º to 25ºC (68º to 77ºF) [See USPControlled Room Temperature].
NDC 0143-9857-25
Rx only
CEFTRIAXONE
FOR INJECTION, USP
1 gram/V ial
EQUIVALENT TO 1 GRAM CEFTRIAXONE
FOR IV OR IM USESingle Dose Vial
PRINCIPAL DISPLAY PANEL
NDC 0143-9856-01
Rx only
CEFTRIAXONE
FOR INJECTION, USP
2 grams/V ial
EQUIVALENT TO 2 GRAMS CEFTRIAXONE
FOR IV OR IM USE
Single Dose Vial
PROTECT FROM LIGHT
For IM administration: Reconstitute with 4.2 mL 1%
Lidocaine Hydrochloride Injection, USP or Sterile
Water for Injection, USP. Each 1 mL of solution con-
tains approximately 350 mg equivalent of ceftriaxone.
For IV administration: Reconstitute with 19.2 mL of
an IV diluent specified in the accompanying package
insert. Each 1 mL of solutin contains approximately
100 mg equivalent of ceftriaxone. Withdraw entire
contents and dilute to the desired concentration with
the appropriate IV diluent.
USUAL DOSAGE and Storage After Reconstitution:
See package insert. Storage Prior to Reconstitution:
Store powder at 20º to 25ºC (68º to 77ºF) [See USPControlled Room Temperature].
NDC 0143-9856-25
Rx only
CEFTRIAXONE
FOR INJECTION, USP
2 grams/V ial
EQUIVALENT TO 2 GRAMS CEFTRIAXONE
FOR IV OR IM USESingle Dose Vial
All MedLibrary.org resources are included in as near-original form as possible, meaning that the information from the original provider has been rendered here with only typographical or stylistic modifications and not with any substantive alterations of content, meaning or intent.